Accuracy of Continuous Central Venous Oxygen Saturation Monitoring in Patients Undergoing Cardiac Surgery by Baulig, Werner et al.
ACCURACY OF CONTINUOUS CENTRAL VENOUS
OXYGEN SATURATION MONITORING IN
PATIENTS UNDERGOING CARDIAC SURGERY
Werner Baulig, MD1, Alexander Dullenkopf, MD1,
Andreas Kobler, MD1, Barbara Baulig, MD1, Hans Rudolf
Roth, PhD2 and Edith R. Schmid, MD1
Baulig W, Dullenkopf A, Kobler A, Baulig B, Roth HR, Schmid ER.
Accuracy of Continuous Central Venous Oxygen Saturation Moni-
toring in Patients Undergoing Cardiac Surgery.
J Clin Monit Comput 2008; 22:183–188
ABSTRACT. Objective. Continuous assessment of central
venous oxygen saturation (ScevoxO2) with the CeVOX device
(Pulsion Medical Systems, Munich, Germany) was evaluated
against central venous oxygen saturation (ScvO2) determined by
co-oximetry. Methods. In 20 cardiac surgical patients, a
CeVOX fiberoptic probe was introduced into a standard central
venous catheter placed in the right internal jugular vein and
advanced 2–3 cm beyond the catheter tip. After in vivo
calibration of the probe, ScevoxO2, ScvO2, mixed venous oxygen
saturation (SmvO2) haemoglobin (Hb), body temperature, heart
rate, central venous and mean arterial pressure, and cardiac index
were assessed simultaneously at 30 min intervals during surgery
and at 60 min intervals during recovery in the intensive care unit.
Agreement between ScevoxO2, and ScvO2 was determined by
Bland-Altman analysis. Simple regression analysis was used to
assess the correlation of ScevoxO2, and ScvO2 to Hb, body
temperature and haemodynamic parameters. Results. Values of
ScevoxO2 and ScvO2 (84 data pairs during surgery and 106 in the
intensive care unit) ranged between 45–89% and 43–90%,
respectively. Mean bias and limits of agreement of ScevoxO2 and
ScvO2 were –0.9 ()7.9/+6.1)% during surgery and )1.2 ()10.5/
+8.1)% in the intensive care unit. In 37.9% of all measured data
pairs, the difference between ScevoxO2 and ScvO2 was beyond
clinically acceptable limits (‡1 s.d.). Mean bias was significantly
influenced by cardiac index. Sensitivity and specificity of ScevoxO2
to detect substantial (‡1 s.d.) changes in ScvO2 were 89 and 82%,
respectively. Conclusions. In adult patients during and after
cardiac surgery, the current version of the CeVOX device might
not be the tool to replace ScvO2 determined by co-oxymetry,
although sensitivity and specificity of ScevoxO2 to predict
substantial changes in ScvO2 were acceptable.
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INTRODUCTION
Central venous oxygen saturation (ScvO2) is an important
parameter for estimating changes in the global oxygen
supply-to-demand ratio in various clinical settings [1, 2]
and one of the core targets for early goal-directed therapy
in the treatment of septic shock [3–6]. Recently, the
Collaborative Study Group in Perioperative ScvO2 Mon-
itoring [7] confirmed the importance of low ScvO2 values
in predicting an increased risk of perioperative complica-
tions in high-risk surgical patients.
Standard means to monitor ScvO2 consist of drawing
repeated blood samples from a central venous catheter
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placed in the superior vena cava and measuring ScvO2 by
co-oximetry [8]. However, this approach is intermittent,
increases workload and costs, and results in contamination
of stopcocks and iatrogenic blood loss. Therefore, reliable
techniques for continuous monitoring of ScvO2 are
desirable. One such technique, based on the principle of
near-infrared spectroscopy [8], is the recently introduced
CeVOX system (Pulsion Medical Systems, Munich,
Germany). To our knowledge, only one experimental
study [9] and two clinical investigations [10, 11] have
been undertaken to evaluate the reliability of the CeVOX
system and factors influencing its accuracy.
The aim of this study was to evaluate the accuracy of
the CeVOX device for continuous assessment of central
venous oxygen saturation (ScevoxO2) against ScvO2
determined by co-oximetry during and after cardiac sur-
gery. In addition, agreement between ScevoxO2 and mixed
venous oxygen saturation (SmvO2) was also documented.
METHODS
The CeVOX system relies on the principle of near-
infrared spectroscopy. Tissue chromophores, such as
haemoglobin absorb near-infrared light depending on
their oxygenation state. Changes in chromophore con-
centrations and oxygenation states, revealed by comparing
emitted and detected near-infrared light, can therefore be
quantified using the modified Lambert-Beer law.
For the purpose of SCevoxO2 monitoring, light of three
wavelengths (660, 805 and 880 nm) is transmitted through
a fiberoptic probe inserted into the distal lumen of a central
venous catheter placed in the superior vena cava. The tip of
the fiberoptic probe must protrude the distal end of the
catheter by 2–3 cm. It is connected to the optical module
of the CeVOX system. Light reflected from the haemo-
globin in the red blood cells is transmitted back by a second
fiberoptic line. The sensor in the optical module analyses
the reflected light and determines light extinction.
This information is transferred to the CeVOX system and
ScevoxO2 is calculated and displayed on the screen.
With ethics committee approval and written, informed
consent, 20 patients scheduled for cardiac surgery with or
without extracorporeal circulation were enrolled in this
prospective, non-randomized, open, monocentre study.
Exclusion criteria were refusal to participate in the study,
hypercoagulation disorders such as factor 5 Leiden disease,
contraindications for insertion of a pulmonary artery
catheter (e.g., surgery of the tricuspid and/or pulmonary
valve, haemoptysis, thrombi within the right heart or
pulmonary artery), contraindications against transesopha-
geal echocardiography (e.g., oesophageal varices, gastric
ulcers, history of recent acute gastric bleeding, narrowing
or stenosis of the oesophagus, Zenker diverticle), and
presence of an open foramen ovale.
Premedication consisted of oral flunitrazepam (1.0–
2.0 mg) the evening before surgery and oral midazolam
(7.5–15 mg) 45 min before transfer to the operating
room. Standard instrumentation included a 2-channel
ECG (leads II and V5) (Hellige SMU 612 monitor,
Marquette Hellige Medical Systems, Freiburg i.Br,
Germany), pulse oximetry using a finger clip (Nellcor
Durasensor, Model DS-100A), and continuous arterial
blood pressure monitoring (Hellige SMU 612 monitor,
Marquette Hellige Medical Systems, Freiburg i.Br,
Germany) via a fluid-filled catheter system (Baxter
Healthcare Corporation Cardiovascular Group, Irvine,
CA, USA) connected to the non dominant radial artery.
Target-controlled intravenous anaesthesia using pro-
pofol (plasma concentration: 1.5–2.5 lg ml)1), supple-
mented by bolus injections of fentanyl (3–10 lg kg)1)
and pancuronium (Organon; 0.1 mg kg)1), was used for
induction of anaesthesia in all patients. Anaesthesia was
maintained with propofol (1.5–2.0 lg ml)1) and remif-
entanil (0.1–0.3 lg.kg)1.min)1). After orotracheal intu-
bation, the patient’s lungs were mechanically ventilated
(Siemens Servo 900; Erlangen, Germany) using a volume-
controlled mode.
A four-lumen central venous catheter (Arrow Inter-
national, Reading, PA, USA) and a 7.5 FG thermistor-
tipped, flow-directed CCO and SmvO2 pulmonary artery
catheter (IntelliCath; Baxter Healthcare Corp.), intro-
duced through an 8.5 FG introducer (Arrow Interna-
tional), were inserted in the right jugular vein. The
pulmonary artery catheter was connected to a cardiac
output computer system (9520A; Baxter Healthcare
Corp.). Cardiac index (CI) was determined by injecting
10 ml of iced saline 0.9% with a closed injectate system
(CO-set; Baxter Healtcare Corp.) Injections were dis-
tributed randomly throughout the respiratory cycle.
Thermodilution curves were displayed on a recorder and
accepted as correct if the shape of the curve fulfilled the
criteria of Levett and Replogle [12] and if the injectate
temperature was <10C.
The CeVOX fiberoptic probe (PV2022-35, Pulsion
Medical Systems) was inserted into the distal lumen of the
central venous catheter. The correct positions of both, the
CeVOX fiberoptic probe tip and the pulmonary artery
catheter tip were verified by transesophageal echocardiog-
raphy before calibration. The CeVOX probe was secured
to the distal end of the central venous catheter lumen by the
integrated luer lock system and connected to the optical
module of the CeVOX system. In vivo calibration was
performed according to the reference manual of the man-
ufacturer. Every 30 min during cardiac surgery (t1–t6) and,
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after recalibration of the CeVOX system, every 60 min
after admission to the intensive care unit (ICU) (t7–t12),
central venous and mixed venous blood samples were
drawn for assessment of ScvO2, SmvO2 and haemoglobin
(Hb) concentration by co-oximetry. Blood samples were
analysed using multi-wavelength haemoximetry (ABL
626/620, Radiometer Medical A/S, Akandevey 21, DK-
2700 Bronshoj, Denmark). Central venous blood samples
were drawn from the distal lumen of the central venous
catheter; the mixed venous blood samples were taken from
the pulmonary lumen of the pulmonary artery catheter.
Simultaneously, ScevoxO2 was recorded, and body tem-
perature, heart rate, central venous pressure, mean arterial
pressure and CI were documented.
Data analysis
A power calculation revealed that a sample size of 20
patients would have 80% power to detect a difference of
‡1 s. d. between ScvO2 and ScevoxO2 using a paired t-test
with a 0.05 two-sided significance level. Agreement be-
tween ScvO2 and ScevoxO2 was determined by Bland-
Altman analysis [13]. Simple regression analysis was used
to correlate mean bias of ScvO2 and ScevoxO2 with Hb,
body temperature, central venous pressure, mean arterial
pressure, and cardiac index. Sensitivity and specificity of
changes in ScevoxO2 to detect changes in ScvO2 and sen-
sitivity and specificity to detect substantial changes (‡1
s.d.) in ScvO2, were determined. A p value of <0.05 was
considered significant. In addition, ScevoxO2 and ScvO2
were correlated with SmvO2.
RESULTS
Patients’ characteristics and haemodynamic data are shown
in Tables 1 and 2. Two hundred twenty-one data pairs of
ScevoxO2 and ScvO2 (115 during surgery and 106 after
admission to the ICU) were recorded. Thirty-one data
pairs were excluded because of detection failure of the
CeVOX fiberoptic probe due to ambient light when the
chest was open. The remaining 190 data pairs (84 during
surgery and 106 in the ICU) were analysed. ScevoxO2 and
ScvO2 values ranged between 45–89% and 43–90%,
respectively. Mean bias and limits of agreement of ScevoxO2
and ScvO2 for all measurements, for measurements during
surgery, and for measurements in the ICU were )1.1
()9.5/+7.3)%, )0.9 ()7.9/+6.1)% (Figure 1) and )1.2
()10.5/+8.1)%, respectively (Figure 2, Table 3). In 37.9%
of all data pairs, the difference between ScevoxO2 and ScvO2
was beyond clinically acceptable limits (‡1 s. d.). A
moderate correlation of the first differences between
ScevoxO2 and ScvO2 was found (Figure 3) and sensitivity and
specificity of ScevoxO2 to detect changes in ScvO2 (n = 168
data pairs) was 76 and 85%, respectively (Figure 3). When
taking into account only substantial changes in ScvO2 (‡1 s.
d.), sensitivity increased to 89% with a specificity of 82%.
Simple regression analyses revealed that the mean bias
of ScevoxO2 and ScvO2 was not influenced by Hb
(P = 0.33), blood temperature (P = 0.23) or mean arterial
pressure (P = 0.94), but an association of the bias was
found with central venous pressure (P = 0.02) and cardiac
index (P = 0.0002). At low cardiac index values, ScevoxO2
overestimated ScvO2, whereas in the high cardiac index
range, ScevoxO2 underestimated ScvO2 (Figure 4). After
the CeVOX fiberoptic probe was removed, no probe
defect or macroscopic visible clot was observed.
Linear correlation between ScevoxO2 and ScvO2 and
between ScevoxO2 and SmvO2 were r
2 = 0.41 and 0.62,
respectively.
DISCUSSION
The main findings of this study are that (i) the agreement
between ScevoxO2 and ScvO2 was poor; (ii) mean bias of
Table 1. Patients’ characteristics
No. of patients 20
Sex (M:F) 12:8
Age (years) 71 (41–84)
Body mass index (kg.m)2) 27.8 (18.8–34.4)
Body surface area (m2 ) 1.87 (1.5–2.4)
Preoperative LV-EF (%) 60 (10–78)
Surgery, no. of patients
OPCAB 8
CABG 2
Valve 7
Valve + CABG 3
Values are expressed as number or median (range). LV-EF, left
ventricular ejection fraction; OPCAB, off-pump coronary artery
bypass; CABG, coronary artery bypass graft; valve + CABG,
combined valve and coronary artery bypass graft surgery.
Table 2. Haemodynamic characteristics
SmvO2 (%) 72.15 (50–89)
Blood temperature (C) 36.6 (31.0–38.6)
Pulse rate (bpm) 83 (40–110)
Mean arterial pressure (mm Hg) 71 (53–95)
Central venous pressure (mm Hg) 9 (0–25)
Cardiac index (l min)1 m)2) 2.6 (1.0–4.5)
Values are expressed as median (range).
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ScevoxO2 and ScvO2 was significantly influenced by cardiac
index; (iii) correlation of first differences between
ScevoxO2 and ScvO2 values was only moderate, but sen-
sitivity of ScevoxO2 to detect substantial changes in ScvO2
were acceptable; and (iv) only a moderate correlation of
ScevoxO2 and ScvO2 with SmvO2. was found.
The techniqual prerequisites for continuous measure-
ments of oxygen saturation in the blood using spectro-
photometry have been available for more than 40 years
[14]. Multiple clinical and experimental investigations
have compared oxygen saturation values derived from
fiberoptic catheters with those obtained by co-oximetry.
Scuderi and colleagues [15] compared three pulmonary
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Fig. 1. Agreement between ScevoxO2 and ScvO2 of 84 data pairs during
surgery. Mean bias, –0.9 %; LOA, )7.9 / + 6.1%.
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Fig. 2. Agreement between ScevoxO2 and ScvO2 of 106 data pairs during
recovery in the ICU. Mean bias, )1.2%; LOA, )10.5 / + 8.13%.
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Fig. 3. First differences of ScevoxO2 (diff ScevoxO2) and ScvO2 (diff ScvO2)
[in %] with R2 = 0.464, P < 0.0001).
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Fig. 4. Influence of cardiac index (L min)1 m)2) on mean bias of Sce-
voxO2 and ScvO2 (%).
Table 3. Bland-Altman analysis of ScevoxO2 and ScvO2 for all
data, data pairs during surgery and data in the ICU
Data pairs n Mean bias LOA
ScevoxO2–ScvO2 (all data) 190 )1.1 )9.5/+7.3
ScevoxO2–ScvO2 (surgery) 83 )0.9 )7.9/+6.1
ScevoxO2–ScvO2 (ICU) 107 )1.2 )10.5/+8.1
ScevoxO2, continuous measured central venous oxygen saturation by
the CeVOX device; ScvO2, central venous oxygen saturation;
LOA, limits of agreement.
186 Journal of Clinical Monitoring and Computing
artery oximetry catheters and reported acceptable agree-
ment with SmvO2 measured by co-oximetry with two of
the three catheters (95% confidence limits: 2.47% and
3.36%, respectively). Burchell and colleagues [16], also
comparing fiberoptic SmvO2 values with SmvO2 assessed
by co-oximetry, interpreted a mean bias of )0.57% and
limits of agreement of ±3.76% as acceptable.
The CeVOX system, investigated here is based on
three reference light wavelengths and characterised by one
transmitting and one detecting fiberoptic filament.
Advantages of this system are that it is easy to handle and
does not necessitate additional invasive venous access
because the disposable 2F fiberoptic catheter can be
inserted into a standard central venous line. Various
lengths (30–48 cm) of the fiberoptic catheter facilitate its
use in connection with a variety of central venous cath-
eters in adults. In the current study the CeVOX moni-
toring device for continuous assessment of central venous
oxygen saturation (ScevoxO2) was compared with central
venous oxygen saturation (ScvO2) determined by
co-oximetry in cardiac surgical patients. This investigation
revealed that the bias of all ScevoxO2 and ScvO2 values was
good, but the limits of agreement were unacceptably high.
Recently, Muller and colleagues [10] investigated the
CeVOX system in three cyanotic infants undergoing
modifications of the stage 1 Norwood procedure. They
reported that the technique is feasible in infants, although
the number of measured data pairs was small and, at ScvO2
values £ 50%, the mean bias and limits of agreement of
ScevoxO2 and ScvO2 were unacceptable.
Most recently, Molnar and colleagues [11] performed a
multicentre study and reported good comparability of
ScevoxO2 and ScvO2 in a heterogeneous group of critically
ill patients, although the limits of agreement were high
()13.2 and 12.5%). Furthermore, in 12 of 53 patients
(>20%) they found a difference of ‡10% at any time point
between ScevoxO2 and ScvO2 values determined by
co-oximetry. This was confirmed in the current study,
were the difference between ScevoxO2 and ScvO2 was
beyond clinically acceptable limits in 37.9% of all data
pairs.
Hofer and colleagues [17] investigated the CeVOX
device in ASA III patients undergoing elective off-pump
coronary artery bypass surgery. They reported that con-
tinuous ScvO2 assessment using CeVOX was reliable. In
their study, the mean bias of ScevoxO2 and ScvO2 was
good, but the limits of agreement during surgery and in
the ICU were as high as in the present study (±8% and
±12%, respectively). Similar to our results, they also found
less agreement between ScevoxO2 and ScvO2 after surgery
than during surgery. It could be hypothesized that the
probability of inadequate volume load and consecutive
vein wall artefacts of the fiberoptic probe is higher in the
ICU. Indeed, in our study the mean central venous
pressure found in the ICU was lower than during surgery
at constant positive end-expiratory pressure. Another
possible explanation for the reduced agreement of the two
methods after surgery may be the time-related higher
probability of clot formations at the tip of the fiberoptic
catheter during recovery in the ICU. Hypercoagulation
states after cardiac surgery with or without cardiopul-
monary bypass are well known [18, 19]. We cannot
definitively exclude this explanation, although no visible
clots were found at the tips of the CeVOX fiberoptic
probes after removal.
Interestingly, the Bland-Altman analysis of the data
pairs collected during and after surgery suggests a nearly
linear dependence of the mean bias of ScevoxO2 and ScvO2
on ScvO2, possibly indicating a systematic error in the
CeVOX algorithm. Most recently Huber and colleagues
[9] compared oxygen saturation values obtained with a 2
French CeVOX fiberoptic probe and a 4 French Edwards
oximetry catheter against values measured by co-oximetry
in an in vitro setting and demonstrated overestimation at
low and underestimation at high oxygen saturations. They
recommended repeated recalibration to reduce the drift of
fiberoptic oxymetry values. In an own most recently
published in vitro study [20] these findings were con-
firmed. One possible reason for the suggested linear
dependency may be a systematic error in the calibration
factor (Cal-Value) of the CeVOX system, recommended
by the manufacturer. But this hypothesis remains to be
determined.
Additionally, the mean bias of ScevoxO2 and ScvO2 in
the present study was significantly influenced by the
Cardiac index: ScevoxO2 overestimated ScvO2 at low CI
values and underestimated it at high values.
First differences between ScevoxO2 and ScvO2 found in
the current investigation showed only a moderate corre-
lation, indicating a considerable number of significant
changes in opposite direction. Only sensitivity and spec-
ificity of ScevoxO2 to detect substantial changes in ScvO2
were acceptable (85 and 82%, respectively).
In agreement with previous investigations [21–23],
neither ScevoxO2 nor ScvO2 reliably reflected SmvO2. The
first differences between ScvO2 and SmvO2 were only
moderately correlated, and changes in ScvO2 only roughly
tracked changes in SmvO2 (data not shown). Correlation
of the first differences between ScevoxO2 and SmvO2 was
even worse.
In conclusion, the current version of the CeVOX de-
vice might not be the tool to replace ScvO2 determined by
co-oxymetry. Even though the sensitivity and specificity
of ScevoxO2 to detect substantial changes in ScvO2 are
acceptable, the current version of the CeVOX device
cannot be recommended for clinical application in high
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risk surgery. Considering the importance of continuous
central venous oxygen saturation monitoring, efforts
should be made to improve the reliability of the CeVOX
device.
There were no financial or non-financial competing interests in the
accomplishment of this study.
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